{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Sol-Gel+Technologies%2C+Ltd.", "query": { "sponsor": "Sol-Gel Technologies, Ltd." }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Sol-Gel+Technologies%2C+Ltd.&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-04T05:24:14.787Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05675501", "title": "Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "Encapsulated Benzoyl Peroxide Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 31, "start_date": "2020-06-10", "completion_date": "2021-07-15", "has_results": false, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05675501" }, { "nct_id": "NCT03761810", "title": "A Study of S6G5T3 in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "S6G5T-3", "type": "DRUG" }, { "name": "S6G5T-8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 434, "start_date": "2018-12-14", "completion_date": "2019-10-23", "has_results": true, "last_update_posted_date": "2021-12-16", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03761810" }, { "nct_id": "NCT06050122", "title": "Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gorlin Syndrome" ], "interventions": [ { "name": "Patidegib Topical Gel", "type": "DRUG" }, { "name": "Patidegib Topical Gel with no active patidegib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 113, "start_date": "2024-03-17", "completion_date": "2026-09-14", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 24, "location_summary": "Rogers, Arkansas • Fremont, California • Los Angeles, California + 21 more", "locations": [ { "city": "Rogers", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06050122" }, { "nct_id": "NCT02842021", "title": "Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tinea Pedis" ], "interventions": [ { "name": "S2G6T-1", "type": "DRUG" }, { "name": "S2G6T-2", "type": "DRUG" }, { "name": "S2G6T-3", "type": "DRUG" }, { "name": "S2G6T-4", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 283, "start_date": "2016-09", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2020-11-18", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 19, "location_summary": "San Diego, California • Clearwater, Florida • North Miami Beach, Florida + 15 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Orange Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842021" }, { "nct_id": "NCT00940992", "title": "A Study of DER 45-EV Gel to Treat Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "DER 45 EV", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 92, "start_date": "2012-01", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2015-01-09", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 10, "location_summary": "Miami, Florida • Augusta, Georgia • Fridley, Minnesota + 6 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Fridley", "state": "Minnesota" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00940992" }, { "nct_id": "NCT02661958", "title": "Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "S6G5T-3", "type": "DRUG" }, { "name": "S6G5T-1", "type": "DRUG" }, { "name": "S6G5T-5", "type": "DRUG" }, { "name": "S6G5T-6", "type": "DRUG" }, { "name": "S6G5T-7", "type": "DRUG" }, { "name": "S6G5T-8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 726, "start_date": "2016-05", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2019-09-19", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 34, "location_summary": "Anaheim, California • Cerritos, California • Chula Vista, California + 27 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661958" }, { "nct_id": "NCT03448939", "title": "A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "S5G4T-1", "type": "DRUG" }, { "name": "S5G4T-2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 361, "start_date": "2018-06-18", "completion_date": "2019-05-24", "has_results": true, "last_update_posted_date": "2021-12-14", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03448939" }, { "nct_id": "NCT04308395", "title": "Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Basal Cell Nevus Syndrome" ], "interventions": [ { "name": "Patidegib Topical Gel, 2%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 108, "start_date": "2020-06-03", "completion_date": "2021-07-14", "has_results": true, "last_update_posted_date": "2024-09-24", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 17, "location_summary": "Fremont, California • Newport Beach, California • New Haven, Connecticut + 14 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Ormond Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04308395" }, { "nct_id": "NCT03727074", "title": "Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis (AK)" ], "interventions": [ { "name": "5-FU Cream", "type": "DRUG" }, { "name": "Efudex®", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 462, "start_date": "2018-12-21", "completion_date": "2019-12-19", "has_results": false, "last_update_posted_date": "2020-03-18", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 1, "location_summary": "Cerritos, California", "locations": [ { "city": "Cerritos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03727074" }, { "nct_id": "NCT04155190", "title": "A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Basal Cell Carcinoma" ], "interventions": [ { "name": "Patidegib Topical Gel, 2%", "type": "DRUG" }, { "name": "Patidegib Topical Gel, Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2019-12-20", "completion_date": "2021-04-23", "has_results": true, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-10-04T05:24:14.787Z", "location_count": 14, "location_summary": "Apple Valley, California • Colton, California • Fremont, California + 11 more", "locations": [ { "city": "Apple Valley", "state": "California" }, { "city": "Colton", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04155190" } ] }